Journal of the Peripheral Nervous System

Papers
(The median citation count of Journal of the Peripheral Nervous System is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Abstracts310
PNS Abstracts 202358
49
33
31
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study25
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”23
Toxic medications in Charcot–Marie–Tooth patients: A systematic review19
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy19
Nerve ultrasound as a screening tool for inherited sensory neuronopathy18
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort16
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)16
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders16
16
Ofatumumab for treating autoimmune nodopathy14
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice14
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study14
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials13
Proximal weakness involvement in the first Italian case of Charcot‐Marie‐Tooth 2CC harboring a novel frameshift variant in NEFH12
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology12
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy11
Issue Information11
Issue Information10
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy10
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)10
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version9
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China9
Sensory neuronopathies: A case series and literature review9
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods9
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy9
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis8
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision8
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A8
Nerve biopsy in acquired neuropathies8
Techniques for the standard histological and ultrastructural assessment of nerve biopsies8
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei8
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study8
Issue Information7
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy7
7
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia7
Issue Information7
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency7
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers6
Issue Information6
6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy6
Issue Information6
Issue Information5
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po5
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy5
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”5
5
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)5
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy5
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes5
ABSTRACT5
The autoimmune vulnerability of the node of Ranvier5
5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience4
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy4
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling4
4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?4
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis4
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies4
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease4
2021 Peripheral Nerve Society virtual event4
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review3
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial3
Anxiety and depression in small fiber neuropathy3
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study3
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy3
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation3
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era3
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor3
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease3
Issue Information3
Issue Information2
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years2
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS)2
2
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria2
Issue Information2
Incidence of Guillain‐Barré syndrome in an Uruguayan population. A prospective cohort study2
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus2
The epidemiology of Guillain‐Barré syndrome in Thailand over 13 years (2005‐2017): A nationwide population‐based retrospective cohort study2
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis2
Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome2
CIDP Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders2
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children2
2
2
Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies2
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies2
Earlier diagnosis of peripheral neuropathy in primary care: A call to action2
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies2
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor2
Abstract2
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal2
Issue Information2
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves2
Phase 2a randomized controlled study investigating the safety and efficacy of PDA‐002 in diabetic peripheral neuropathy2
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury2
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis2
A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease1
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?1
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome1
Correction to “Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study”1
Serum neurofilament light chain measurements following nerve trauma1
Laura Feltri: In memoriam1
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study1
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation1
Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges1
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN11
Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement1
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients1
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review1
Leptospirosis‐induced acute acquired inflammatory neuropathy1
Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome1
1
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response1
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy1
Issue Information1
Issue Information1
Charcot‐Marie‐Tooth disease: Genetic profile of patients from a large Brazilian neuromuscular reference center1
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome1
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy1
Digital nerve reconstruction with a new composite silk fibroin nerve conduit1
Unusual upper limb features in SORD neuropathy1
Issue Information1
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity1
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)1
Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy1
Normal structure and pathological features in peripheral neuropathies1
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study1
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report1
Issue Information1
New Approaches Based on Serial‐Block Face Electron Microscopy to Investigate the Peripheral Nervous System1
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy1
Identification of cellular and noncellular components of mature intact human peripheral nerve1
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla1
Issue Information0
Nodes of Ranvier in health and disease0
Abstracts of the 32nd Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)0
DNMT1‐associated sensory neuropathy and cerebellar ataxia: A novel variant and review of genotype–phenotype correlation0
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies0
Abstracts of the Eleventh Annual Meeting of the Associazione Italiana Sistema Nervoso Periferico (ASNP)0
Wearables, sensors, and smart devices for the detection and monitoring of chemotherapy‐induced peripheral neurotoxicity: Systematic review and directions for future research0
Unveiling the clinical and electrophysiological profile of CMTX6: Insights from two Brazilian families0
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy‐induced peripheral neurotoxicity: The role of nerve excitability testing0
A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course0
Issue Information0
Featured Cover0
Correction to ‘Serum neurofilament light chain measurements following nerve trauma’0
Correction to “Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)”0
Hereditary neuropathies: A pathological perspective0
A deep intronic variant in MME causes autosomal recessive Charcot–Marie–Tooth neuropathy through aberrant splicing0
0
Report of a fulminant anti‐pan‐neurofascin‐associated neuropathy responsive to rituximab and bortezomib0
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents0
0
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models0
Correction to “Earlier diagnosis of peripheral neuropathy in primary care: A call to action”0
Physical exercise halts further functional decline in an animal model for Charcot–Marie–Tooth disease 1X at an advanced disease stage0
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ) for identifying pure small fiber neuropathy0
The neuropathy in hereditary transthyretin amyloidosis: A narrative review0
Issue Information0
Sural nerve biopsy utility by masked assessment of individual histologic preparations0
Issue Information0
Prediction of respiratory failure and prolonged mechanical ventilation in Guillain‐Barré syndrome: A prospective cohort study in Bangladesh0
PNS 2022 Abstract Supplement0
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report0
No evidence of improvement in neuropathy after renal transplantation in patients with end stage kidney disease0
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy‐induced painful peripheral neuropathy0
Clinical and laboratory findings in scrub typhus associated Guillain‐Barré syndrome in South Korea0
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?0
Development of a functional outcome measure for riboflavin transporter deficiency0
0
Two new mouse models of Gjb1‐associated Charcot–Marie–Tooth disease type 1X0
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A10
Differences in the ultrastructure of neurons in the spinal ganglion and dorsal rootlet between rats treated with cisplatin only versus co‐administration with a sphingosine 1‐phosphate receptor 2 agoni0
Issue Information0
Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro0
Distinguishing Chronic Inflammatory Demyelinating Polyneuropathy From Mimic Disorders: The Role of Statistical Modeling0
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome0
Issue Information0
Recruiting for an International Rare Disease Clinical Trial Readiness Study during the COVID‐19 pandemic: Challenges and solutions0
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy0
Noncanonical splice‐site variant in peripheral myelin protein 22 gene (PMP22) in a patient with hereditary neuropathy with liability to pressure palsies0
Electrodiagnostic subtyping in Guillain‐Barré syndrome: Use of criteria in practice based on a survey study in IGOS0
0
Nodal–paranodal antibodies in HIV‐immune mediated radiculo‐neuropathies: Clinical phenotypes and relevance0
Genotype–phenotype correlations of AR‐CMT2S in a cohort of axonal Charcot–Marie–Tooth patients from Central South China0
Knowledge gaps in diagnosing chronic polyneuropathy: Review of national guidelines0
Inter‐rater reliability of the Rasch‐modified medical research council scoring criteria for manual muscle testing in neuromuscular diseases0
GJB1 variants in Charcot‐Marie‐Tooth disease X‐linked type 1 in Mali0
Vestibular impairment in Guillain‐Barré syndrome0
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity in breast cancer patients0
A previously unreported NARS1 variant causes dominant distal hereditary motor neuropathy in a French family0
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO)0
Clinical scoring systems for the risk of cardiovascular autonomic neuropathy in type 1 and type 2 diabetes: A simple tool0
Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre Survey0
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome0
Issue Information0
0
Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus0
0
HINT1‐related neuropathy in Greek patients with Charcot‐Marie‐Tooth disease0
Issue Information0
Autoimmune nodo‐paranodopathies 10 years later: Clinical features, pathophysiology and treatment0
PNS Abstracts 20240
The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy0
Loss of function MPZ mutation causes milder CMT1B neuropathy0
Cardiovascular autonomic neuropathy in patients with type 2 diabetes with and without sensorimotor polyneuropathy0
CYBA allelic variants are associated with severity and recovery in Guillain–Barré syndrome0
Dorsal root ganglia CSF1+ neuronal subtypes have different impact on macrophages and microglia after spared nerve injury0
EGR2 gene‐linked hereditary neuropathies present with a bimodal age distribution at symptoms onset0
An approach to assessing immunoglobulin dependence in chronic inflammatory demyelinating inflammatory polyneuropathy0
0
Issue Information0
Electrodiagnostic methods to verify Guillain‐Barré syndrome subtypes in Istanbul: A prospective multicenter study0
Nerve pathology in animal models of neuropathies0
Corneal confocal microscopy detects early nerve regeneration after pharmacological and surgical interventions: Systematic review and meta‐analysis0
Issue Information0
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy0
The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murineGuillain‐Barrésyndrome0
Evidence for spontaneous regulation of the humoral IgM anti‐GM1 autoimmune response by IgG antibodies in multifocal motor neuropathy patients0
Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands0
Featured Cover0
Serum anti‐GM2 and anti‐GalNAc‐GD1a ganglioside IgG antibodies are biomarkers for immune‐mediated polyneuropathies in cats0
The neurological core features of the infantile‐onset multisystem neurologic, endocrine, and pancreatic disease: A novel nonsense mutation in an Italian family0
Clinical features of a family with late‐onset distal hereditary motor neuropathy harboring p.Pro39Leu variant of HSPB10
0
0
Severe distinct dysautonomia in RFC1‐related disease associated with Parkinsonism0
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision0
Ophthalmological involvement in wild‐type transthyretin amyloidosis: A multimodal imaging study0
Issue Information0
Successful autologous hematopoietic stem cell transplantation in a refractory anti‐Caspr1 antibody nodopathy0
Conduction block and temporal dispersion in a SIGMAR1‐related neuropathy0
Charcot‐Marie‐Tooth disease in Africa0
Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review0
0
Issue Information0
Issue Information0
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy0
Associations of Guillain‐Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database0
Management of Guillain–Barré syndrome in Bangladesh: Clinical practice, limitations and recommendations for low‐ and middle‐income countries0
Nerve ultrasound in CANVAS‐spectrum disease: Reduced nerve size distinguishes genetically confirmed CANVAS from other axonal polyneuropathies0
0.11799812316895